Trump Orders Fast Review of Psychedelics, Ibogaine
April 19, 2026·about 2 hours ago·via The Washington Post

President Trump signs an executive order speeding FDA review of psychedelics, including controversial ibogaine for addiction and trauma. This cuts government bloat, unleashing therapies stifled by regulators for decades and empowering veterans with real healing options. America First triumphs over deep-state control, favoring patient choice and innovation against pharma monopolies. A sharp rebuke to liberal nannyism that keeps Americans suffering. Read more about this...